2021 Multidisciplinary Oncology Symposium
The 2021 Multidisciplinary Oncology Symposium is a one-day conference specifically designed for community oncology providers and other healthcare professionals involved in the care of cancer patients. Expert faculty will review and critically assess the results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast, lung, and prostate cancers. We will utilize various strategies to facilitate learning, including case-based panels discussion and an audience response system.
- Audience response system
- Didactics and case-based discussions
- Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
- Opportunities to network with colleagues and faculty members.
- Programs topics can immediately be applied to clinical practice.
Through didactic lectures, case-based presentations, and questions and answer sessions, attendees will be able to learn about the new developments in the field of breast, lung and prostate cancers and have their questions answered. Attendees will also have opportunity to network with faculty if they have questions. The use of audience response system will provide faculty with immediate feedback on attendee’s ability to grasp the presentation and might help clarify topics that need further explanation during the questions and answers session.
Upon successful completion of this educational activity, participants will be able to:
- Review pertinent clinical trial data for standard of care and novel management strategies for various solid tumors.
- Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care for patients with breast, lung and prostate cancers.
- Identify side effects, indications, and contra-indications of various therapies used to diagnose and treat breast, lung and prostate cancers, and explain how to effectively manage those side-effects
- Integrate emerging evidence into treatment paradigms for treatment of patients
January 22, 2022
All times are in Pacific Time Zone
06:30 AM – 07:45 AM PST Registration/Networking
07:45 AM – 08:00 AM PST Welcome
08:00 AM – 08:30 AM PST Advances in (Neo)adjuvant therapies in breast cancer
08:30 AM – 09:00 AM PST Current approach in management of advanced breast cancer
09:00 AM – 09:30 AM PST Case-based panel discussion
09:30 AM – 10:00 AM PST Break
10:00 AM – 10:30 AM PST Targeted (neo)adjuvant therapies in non-small cell lung cancer
10:30 AM – 11:00 AM PST Biomarker-guided treatment of advanced non-small cell lung cancer
11:00 AM – 11:30 AM PST Case-based panel discussion
11:30 PM – 01:00 PM PST Lunch
01:00 PM – 01:30 PM PST Initial management of advanced prostate cancer
01:30 PM – 02:00 PM PST Management of recurrent prostate cancer
02:00 PM – 02:30 PM PST Case-based panel discussion
02:30 PM – 03:00 PM PST Break
03:30 PM – 04:00 PM PST Updates in management of CLL
04:00 PM – 04:30 PM PST Recent updates in management of diffuse large B cell lymphoma
04:30 PM – 05:00 PM PST Case-based panel discussion
05:00 PM – 05:05 PM PST Adjourn
Faculty information coming soon.....
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 6.0 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6 Contact Hours.
- 6.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 6.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
- 0.00 Participation
Physicians (MD/DO) - $150
Non-Physician (RN/NP/PA/PharmD) - $75
Resident/Fellow - $75
Non-displaying industry representative - $550
Displaying industry representative (not covered by the display fee) - $450 (Displaying reps must register using this link - https://education.binayfoundation.org/industry_registraiton_nocme)
If you are employed by the industry, you must register as "Industry representative" even if you are a licensed healthcare provider not involved in the sales of product. The industry price is applicable to everyone who are employed by an ACCME defined ineligible company.